Bio-Path (BPTH) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free BPTH Stock Alerts $2.68 +0.04 (+1.52%) (As of 03:59 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBio-Path (NASDAQ:BPTH) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - April 24 at 2:38 AMBio-Path (NASDAQ:BPTH) Rating Reiterated by Roth Mkmamericanbankingnews.com - April 20 at 1:54 AMBio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesglobenewswire.com - April 19 at 12:14 PMCrude Oil Edges Lower; Bio-Path Holdings Shares Spike Highermsn.com - April 18 at 2:18 PMWhy Bio-Path Stock Is Soaringmsn.com - April 18 at 2:18 PMmarketbeat.com - April 18 at 2:00 PMBio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesglobenewswire.com - April 18 at 1:57 PMmarketbeat.com - April 18 at 11:42 AMWhy Is Bio-Path (BPTH) Stock Up 89% Today?investorplace.com - April 18 at 10:28 AMmarketbeat.com - April 18 at 10:08 AMmarketbeat.com - April 18 at 9:39 AMBio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patientsglobenewswire.com - April 18 at 7:00 AMBio-Path expands patent portfolio in multiple countriesuk.investing.com - April 17 at 7:31 PMBio-Path Holdings, Inc.: Bio-Path Holdings Expands Global Patent Portfoliofinanznachrichten.de - April 17 at 9:30 AMBio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Updateamericanbankingnews.com - April 17 at 5:12 AMBioPath Hikes on International Patentsbaystreet.ca - April 15 at 10:18 AMBio-Path Holdings Expands Global Patent Portfolioglobenewswire.com - April 15 at 7:00 AMBio-Path Holdings Inc BPTHmorningstar.com - April 13 at 2:46 PMDiscovery of a fundamental biological mechanism opens path for novel therapiesmsn.com - April 5 at 3:26 AMBio-Path Holdings shares sink 6% after deal for at-the-market offeringmsn.com - April 4 at 10:25 PMBio-Path Holdings Provides 2024 Clinical and Operational Updateglobenewswire.com - April 2 at 7:00 AMmarketbeat.com - April 1 at 3:12 PMmarketbeat.com - March 26 at 9:38 AMBharat Biotech starts TB vaccine’s trials in adultsmsn.com - March 26 at 12:07 AMBio-Path Shares Close Lower After Withdrawing S-1marketwatch.com - March 25 at 7:03 PMmarketbeat.com - March 25 at 10:16 AMmarketbeat.com - March 25 at 10:07 AMBioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 13 at 10:37 AMmarketbeat.com - March 12 at 2:24 PMBio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 10 at 6:06 PMBio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 10 at 1:05 PMWhy Bio-Path Holdings Shares Are Falling Todaymsn.com - March 8 at 5:48 PMBio-Path files to sell 1.15M shares of common stock, warrantsmsn.com - March 8 at 5:48 PMBio-Path Holdings, Inc.: Bio-Path Holdings Reports Full Year 2023 Financial Resultsfinanznachrichten.de - March 8 at 12:48 PMBio-Path Holdings Reports Full Year 2023 Financial Resultsglobenewswire.com - March 8 at 7:00 AMBio-Path Holdings's Earnings: A Previewbenzinga.com - March 7 at 9:48 AMBio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024globenewswire.com - March 1 at 7:00 AMBio-Path Holdings (BPTH) Price Target Increased by 1900.00% to 244.80msn.com - February 24 at 3:43 AMmarketbeat.com - February 23 at 6:11 AMBio-Path Hldgs Stock (NASDAQ:BPTH) Dividends: History, Yield and Datesbenzinga.com - February 22 at 10:23 AMBio-Path Holdings, Inc.: Bio-Path Holdings Announces 1-for-20 Reverse Stock Splitfinanznachrichten.de - February 21 at 1:13 PMBio-Path Holdings Announces 1-for-20 Reverse Stock Splitfinance.yahoo.com - February 21 at 8:12 AMBio-Path Holdings Announces 1-for-20 Reverse Stock Splitglobenewswire.com - February 21 at 7:00 AMBio Path Holdings Inc (BPTH)investing.com - February 10 at 11:14 PMBio-Path Holdings Inc.wsj.com - January 23 at 4:46 PMPragma Bio and DayTwo Join Forces to Illuminate the Path to IBD Disease Managementbusinesswire.com - January 17 at 11:42 PMBPTH Bio-Path Holdings, Inc.seekingalpha.com - January 14 at 11:57 PMBio-Path concludes first cohort of Phase I lymphoma trialmsn.com - January 11 at 3:38 PMBio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patientsfinance.yahoo.com - January 10 at 12:15 PMBio-Path files to sell sharesmsn.com - December 22 at 8:30 PM Get Bio-Path News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. BPTH Media Mentions By Week BPTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPTH News Sentiment▼0.400.33▲Average Medical News Sentiment BPTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPTH Articles This Week▼31▲BPTH Articles Average Week Get Bio-Path News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GLMD News PRFX News LSDI News QLGN News INM News CMND News ATNF News NBSE News HSTO News SLRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPTH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
